VICTOR GONZALEZ: Open Payments
NPI 1336528157 · LAREDO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$390 in 16 payments from 8 companies in 2025. Trend: 2023 $483 · 2024 $454 · 2025 $390
Food & beverage: $390
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. | 1 | $123 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $80 |
| Axsome Therapeutics, Inc. | 3 | $46 |
| Janssen Pharmaceuticals, Inc | 2 | $44 |
| Bausch Health US, LLC | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Corium, LLC | 1 | $8 |
Products named: MIEBO, CAPLYTA, Auvelity, SPRAVATO, APLENZIN, NUEDEXTA, FANAPT, REXULTI.
Industry payments across TX — which companies pay providers there.
